BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24829194)

  • 21. Serum HE4 as a diagnostic and prognostic marker for lung cancer.
    Iwahori K; Suzuki H; Kishi Y; Fujii Y; Uehara R; Okamoto N; Kobayashi M; Hirashima T; Kawase I; Naka T
    Tumour Biol; 2012 Aug; 33(4):1141-9. PubMed ID: 22373583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum Human Epididymis Protein-4 (HE4) - A novel Approach to Differentiate Malignant Frombenign Breast Tumors.
    Sai Baba KSS; Rehman MA; Pradeep Kumar J; Fatima M; Raju GSN; Uppin SG; Mohammed N
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2509-2507. PubMed ID: 34452565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of HE4 and TTR for diagnosis of ovarian cancer: Comparison with CA-125.
    Zheng X; Chen S; Li L; Liu X; Liu X; Dai S; Zhang P; Lu H; Lin Z; Yu Y; Li G
    J Gynecol Obstet Hum Reprod; 2018 Jun; 47(6):227-230. PubMed ID: 29609043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined detection of sialic acid and hydroxyproline in diagnosis of ovarian cancer and its comparison with human epididymis protein 4 and carbohydrate antigen 125.
    Li PL; Zhang X; Li TF; Wang LL; Du LT; Yang YM; Li J; Wang HY; Zhang Y; Wang CX
    Clin Chim Acta; 2015 Jan; 439():148-53. PubMed ID: 25445414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Müllerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors.
    Haltia UM; Hallamaa M; Tapper J; Hynninen J; Alfthan H; Kalra B; Ritvos O; Heikinheimo M; Unkila-Kallio L; Perheentupa A; Färkkilä A
    Gynecol Oncol; 2017 Jan; 144(1):83-89. PubMed ID: 27871721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revised Cut-Off Value of Human Epididymis Protein 4 Enhances Its Use as an Ovarian Tumor Marker.
    Machida H; Hirakawa T; Tsunekawa K; Kimura T; Murakami M; Abe Y
    Gynecol Obstet Invest; 2023; 88(6):349-358. PubMed ID: 37788640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of HE4 for ovarian cancer: a meta-analysis.
    Yu S; Yang HJ; Xie SQ; Bao YX
    Clin Chem Lab Med; 2012 Feb; 50(8):1439-46. PubMed ID: 22868811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population.
    Kim YM; Whang DH; Park J; Kim SH; Lee SW; Park HA; Ha M; Choi KH
    Clin Chem Lab Med; 2011 Mar; 49(3):527-34. PubMed ID: 21320028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?
    Azzam AZ; Hashad DI; Kamel NA
    Arch Gynecol Obstet; 2013 Jul; 288(1):167-72. PubMed ID: 23361457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated Serum Human Epididymis Protein 4 Is Associated With Disease Activity and Systemic Involvements in Primary Sjögren's Syndrome.
    Chen J; Sun F; Bao H; Liang L; Zhan M; Yao H; He J; Liu Y
    Front Immunol; 2021; 12():670642. PubMed ID: 34248951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of individual biology in the clinical use of serum biomarkers for ovarian cancer.
    Braga F; Ferraro S; Mozzi R; Panteghini M
    Clin Chem Lab Med; 2014 Nov; 52(11):1625-31. PubMed ID: 24829196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum level of HE4 is closely associated with pulmonary adenocarcinoma progression.
    Yamashita S; Tokuishi K; Moroga T; Yamamoto S; Ohbo K; Miyahara S; Yoshida Y; Yanagisawa J; Hamatake D; Hiratsuka M; Yoshinaga Y; Shiraishi T; Iwasaki A; Kawahara K
    Tumour Biol; 2012 Dec; 33(6):2365-70. PubMed ID: 23001907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer.
    Anderson KS; Wong J; Vitonis A; Crum CP; Sluss PM; Labaer J; Cramer D
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):859-68. PubMed ID: 20200435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).
    Antonsen SL; Høgdall E; Christensen IJ; Lydolph M; Tabor A; Loft Jakobsen A; Fagö-Olsen CL; Andersen ES; Jochumsen K; Høgdall C
    Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1313-22. PubMed ID: 24032654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human epididymis protein 4, a novel potential biomarker for diagnostic and prognosis monitoring of lung cancer.
    Zhang T; Chu L; Tan W; Ye C; Dong H
    Clin Respir J; 2024 May; 18(5):e13774. PubMed ID: 38742362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study.
    Capriglione S; Plotti F; Miranda A; Ricciardi R; Scaletta G; Aloisi A; Guzzo F; Montera R; Angioli R
    Tumour Biol; 2015 Jun; 36(6):4151-6. PubMed ID: 25577252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of human epididymis protein 4 in endometrial cancer and its utility for surgical staging.
    Minar L; Klabenesova I; Jandakova E; Zlamal F; Bienertova-Vasku J
    J Obstet Gynaecol Res; 2015 Oct; 41(10):1644-52. PubMed ID: 26223178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients.
    Omer B; Genc S; Takmaz O; Dirican A; Kusku-Kiraz Z; Berkman S; Gurdol F
    Tumour Biol; 2013 Oct; 34(5):2645-50. PubMed ID: 23640061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer.
    Knific T; Osredkar J; Smrkolj Š; Tonin I; Vouk K; Blejec A; Frković Grazio S; Rižner TL
    Gynecol Oncol; 2017 Oct; 147(1):126-132. PubMed ID: 28735628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical significance of DJ-1 and HE4 in patients with endometrial cancer.
    Benati M; Montagnana M; Danese E; Paviati E; Giudici S; Ruzzenente O; Franchi M; Lippi G
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.